From the demonstration of the existence of multiple opioid receptors and th
e isolation of the endogenous opioid peptides in the brain, it is now clear
that the activities of these receptors can be regulated at various levels.
The distinct brain regional distribution of the receptor suggests a tight
transcriptional regulation. Early findings of alterations in receptor bindi
ng associated with tolerance to the opioids implies that the receptor life
cycle can be influenced by the presence of agonists. Until the recent repor
ted cloning of opioid receptors, the detailed studies of the molecular mech
anisms involved in their regulation could not be conducted. With the availa
bility of the cDNA clones of the mu-, delta- and kappa-opioid receptors, an
d the elucidation of their gene structures, it is now possible to investiga
te opioid receptor regulation at various levels, and to identify the specif
ic receptors involved in the pharmacological actions of the opioids. It is
now also possible to define the receptor domains responsible for the opioid
ligand selectivities, agonist activation, and agonist-induced inactivation
. Summarized in this report are our past efforts in defining the regulation
of opioid receptor activities. Studies using heterologous expression techn
iques, mutational analysis of receptors to characterize transcriptional ele
ments, and the in vivo manipulation of the receptor gene levels have made i
t is possible to determine the mechanisms whereby these receptors are regul
ated. Our studies have also identified the unique characteristics of opioid
receptors as members of the superfamily of G protein-coupled receptors.